肺部感染“医保”住院患者抗菌药物应用分析

Analysis of Antibiotics Used by Medical Insured Inpatients with Lung Infection

目的：了解肺部感染“医保”住院患者抗菌药物的应用情况，为加强“医保”住院患者抗菌药物费用管理提供参考。方法：统计2004年1月～2006年6月福州市685例肺部感染住院患者的“医保”数据库资料，采用限定日剂量、销售金额／用药频度序号比等方法，对患者住院期间抗菌药物的应用及费用情况进行统计、分析。结果：销售金额及用药频度靠前的是头孢菌素类和喹诺酮类，二者的合计费用占肺部感染抗菌药物总费用的70．70％。结论：头孢菌素类、喹诺酮类用药是影响住院费用的主要因素，应重点监管。

OBJECTIVE： To investigate the use of antibiotics in medical insured inpatients with lung infection for reference of management of expenditure of antibiotics in the inpatients. METHODS： The data base documents of a total of 685 insured inpatients with lung infection（Jan .2004-Jun .2006） were collected for a statistical analysis in respect of the utilization and expenditure of antibitoics using defined daily dose and the ratio of order of consumption sum to that of DDDs as indexes. RESULTS： Cephalosporins and quinolones took the lead in expenditure and DDDs, accounting for 70.70% of total antibiotics in terms of consumption sum.CONCLUSION： The main factors affecting hospitalization expense were the application of cephalosporins and quinolones, thus emphasis should be paid to the supervising of these factors.